Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis.
暂无分享,去创建一个
[1] M. Valenti,et al. Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells. , 2008, Bone.
[2] J. Rodríguez,et al. Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis. , 2008, Current stem cell research & therapy.
[3] Anita H. Undale,et al. Characterization of circulating osteoblast lineage cells in humans. , 2007, Bone.
[4] Lindolfo da Silva Meirelles,et al. Mesenchymal stem cells reside in virtually all post-natal organs and tissues , 2006, Journal of Cell Science.
[5] J. Rubin,et al. Transcriptional Regulation of the Osterix (Osx, Sp7) Promoter by Tumor Necrosis Factor Identifies Disparate Effects of Mitogen-activated Protein Kinase and NFκB Pathways* , 2006, Journal of Biological Chemistry.
[6] B. Riggs,et al. Circulating osteoblast-lineage cells in humans. , 2005, The New England journal of medicine.
[7] K. Le Blanc,et al. Mesenchymal stem cells: progress toward promise. , 2005, Cytotherapy.
[8] Vincent Lemaire,et al. Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. , 2004, Journal of theoretical biology.
[9] Hyo-Sang Park,et al. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. , 2003, Biochemical and biophysical research communications.
[10] K. Nakashima,et al. Transcriptional mechanisms in osteoblast differentiation and bone formation. , 2003, Trends in genetics : TIG.
[11] G. Xiao,et al. Regulation of the osteoblast‐specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways , 2003, Journal of cellular biochemistry.
[12] J. Deng,et al. The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.
[13] E. Sage,et al. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. , 2001, The Journal of clinical investigation.
[14] G. Karsenty,et al. Cbfa1 Contributes to the Osteoblast-specific Expression of type I collagen Genes* , 2001, The Journal of Biological Chemistry.
[15] C. Damsky,et al. Collagen Integrin Receptors Regulate Early Osteoblast Differentiation Induced by BMP‐2 , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] M. Pittenger,et al. Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.
[17] H. Yasuda,et al. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. , 1998, Biochemical and biophysical research communications.
[18] K Yano,et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. , 1998, Biochemical and biophysical research communications.
[19] S. Mundlos,et al. Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.
[20] G. Karsenty,et al. Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.
[21] A. Villanueva,et al. Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] J. Kanis,et al. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report , 1994, Osteoporosis International.
[23] R T Turner,et al. Skeletal effects of estrogen. , 1994, Endocrine reviews.
[24] B. Ziegler,et al. Phenotype analysis of hematopoietic CD34+ cell populations derived from human umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction. , 1994, Blood.
[25] Claus Christiansen,et al. Diagnosis of Osteoporosis , 1992, Southern medical journal.
[26] B. Hogan,et al. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization , 1988, The Journal of cell biology.
[27] P Meunier,et al. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. , 1971, Clinical orthopaedics and related research.
[28] N. Udagawa,et al. Action of RANKL and OPG for osteoclastogenesis. , 2009, Critical reviews in eukaryotic gene expression.
[29] Thomas D. Schmittgen,et al. Real-Time Quantitative PCR , 2002 .
[30] M. McKee,et al. Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. , 1996, Connective tissue research.
[31] B. Olsen,et al. FACIT collagens: diverse molecular bridges in extracellular matrices. , 1991, Trends in biochemical sciences.